(Q37687695)
Statements
Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model (English)
Robert M Hoffman
Tara A Russell
Fritz C Eilber
Tasuku Kiyuna
Michiaki Unno
Kei Kawaguchi
Scott D Nelson
Sarah M Dry
1 November 2016
1 reference
1 reference
1 reference